Pornpimon Yuti
Bangkok, 10700, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Triple-costimulatory GD2-CAR T cells incorporating CD28, 4-1BB and CD27 mediate potent cytotoxicity and reduce exhaustion in solid tumour models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 21, 2026
Intravitreal GD2-Specific Chimeric Antigen Receptor T-Cell Therapy for Refractory Retinoblastoma.
Journal: Pediatric blood & cancer
Published: November 02, 2025
Dual targeting of BCMA and B7-H3 with CAR T cells and bispecific protein engagers enhances anti-myeloma activity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 01, 2025
Enhanced antitumor efficacy of next-generation B7-H3 chimeric antigen receptor T cells containing CD28, CD137 and CD27 costimulatory domains in multiple myeloma.
Journal: Cytotherapy
Published: July 29, 2025
Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv.
Journal: Journal of translational medicine
Published: October 29, 2024
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach.
Journal: Journal of translational medicine
Published: August 08, 2024
Bispecific T cell engager-armed T cells targeting integrin ανβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 12, 2024
Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer.
Journal: International immunopharmacology
Published: September 20, 2023
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma.
Journal: Clinical and experimental medicine
Published: August 30, 2023
Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 26, 2023
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition.
Journal: International immunopharmacology
Published: August 18, 2022
Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains.
Journal: Frontiers in oncology
Published: October 27, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026